Condition
Adenoviral Keratoconjunctivitis
Total Trials
4
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 4 (1)
Trial Status
Unknown2
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05123014Not ApplicableActive Not RecruitingPrimary
Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
NCT04417244UnknownPrimary
Adenovirus Keratoconjunctivitis and Ophtalmology
NCT04376970Phase 4CompletedPrimary
Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis
NCT04041856Phase 1UnknownPrimary
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
Showing all 4 trials